Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction
- 1 December 2017
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 337, 45-66
Abstract
No abstract availableKeywords
Funding Information
- National Science Fund of Bulgaria (DM 01/1/2016)
- COST action (CM1704)
- National Science Fund of Bulgaria (DKOCT 01/11/2016)
This publication has 110 references indexed in Scilit:
- Evaluation of Estrogenic Potential of Flavonoids Using a Recombinant Yeast Strain and MCF7/BUS Cell Proliferation AssayPLOS ONE, 2013
- Ursolic Acid Inhibits Adipogenesis in 3T3-L1 Adipocytes through LKB1/AMPK PathwayPLOS ONE, 2013
- Aggrephagy: Selective Disposal of Protein Aggregates by MacroautophagyInternational Journal of Cell Biology, 2012
- Quantifying the chemical beauty of drugsNature Chemistry, 2012
- The Role of Metformin in the Management of NAFLDExperimental Diabetes Research, 2011
- Distinct Biological Network Properties between the Targets of Natural Products and Disease GenesJournal of the American Chemical Society, 2010
- AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectivesActa Physiologica, 2009
- Autophagy regulates lipid metabolismNature, 2009
- Review: Treatment options for nonalcoholic fatty liver diseaseTherapeutic Advances in Gastroenterology, 2008
- Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disordersThe Journal of Physiology, 2006